田村 厚久 たむら あつひさ 先生

来歴等

略歴

1982年 東京医科歯科大学医学部 卒業
1982年 東京医科歯科大学医学部 第一内科 研修医
1983年 都立墨東病院 内科
1985年 東京医科歯科大学 第一内科（呼吸器）
1993年 国立療養所東京病院（現・独立行政法人国立病院機構東京病院） 呼吸器内科
2020年 独立行政法人国立病院機構東京病院 呼吸器内科 統括診療部長
2022年 独立行政法人国立病院機構東京病院 呼吸器内科 副院長
2024年 独立行政法人国立病院機構東京病院 呼吸器内科 呼吸器センター長

論文

• 1. Predicting systemic therapy toxicity in older adult patients with advanced non-small cell lung cancer: A prospective multicenter study of National Hospital Organization in Japan. J Geriatr Oncol 2022;13:1216-22.

  Kanazu M, Shimokawa M, Saito R, Mori M, Tamura A, Okano Y, Fujita Y, Endo T, Motegi M, Takata S, Kita T, Sukoh N, Takenoyama M, Atagi S.

• 2. Impact of lung cancer surgery on comorbid Mycobacterium avium complex lung disease—A case series. Respir Med Case Rep. 2022;37:101664.

  Tamura A, Kawashima M, Suzuki J, Yamane A, Inoue Y, Fukami T, Kitani M, Takahashi F.

• 3. First-Line Pembrolizumab Monotherapy for Advanced NSCLC With Programmed Death-Ligand 1 Expression Greater Than or Equal to 50%:Real-World Study Including Older Patients in Japan. JTO Clin Res Rep. 2022 ;3:100397.

  Goto Y, Tamura A, Matsumoto H, Isobe K, Ozaki T, Santorelli ML, Taniguchi K, Kamitani T, Irisawa M, Kanda K, Abe M, Burke T, Nokihara H.

• 4. Tuberculosis during lung cancer treatment-A case series. J Infect Chemother. 2022;28:339-42.

  Tamura A, Ikeda M, Shimada M, Yamane A.

• 5. Sequential therapy of crizotinib followed by alectinib for non-small cell lung cancer harbouring anaplastic lymphoma kinase rearrangement (WJOG9516L): A multicenter retrospective cohort study. Eur J Cancer. 2021;145:183-93.

  Ito K, Yamanaka T, Hayashi H, Hattori Y, Nishino K, Kobayashi H, Oya Y, Yokoyama T, Seto T, Azuma K, Fukui T, Kozuki T, Nakamura A, Tanaka K, Hirano K, Yokoi T, Daga H, Sakata S, Fujimoto D, Mori M, Maeno K, Aoki T, Tamura A, Miura S, Watanabe S, Akamatsu H, Hataji O, Suzuki K, Hontsu S, Azuma K, Bessho A, Kubo A, Okuno M, Nakagawa K, Yamamoto N.

• 6. Recent trends in the incidence of latent tuberculosis infection in Japanese patients with lung cancer: a small retrospective study. J Infect Chemother 2020;26, 315-7.

  Tamura A, Fukami T, Hebisawa A, Takahashi F.

• 7. Assessment of sleep disturbance in lung cancer patients: relationship between sleep disturbance and pain, fatigue, quality of life, and psychological distress. Palliat Support Care. 2015;13:575-81.

  Nishiura M, Tamura A, Nagai H, Matsushima E.

• 8. Chronic pulmonary aspergillosis as a sequel to lobectomy for lung cancer. Interact Cardiovasc Thorac Surg. 2015;21:650-6.

  Tamura A, Suzuki J, Fukami T, Matsui H, Akagawa S, Ohta K, Hebisawa A, Takahashi F.

• 9. Randomized phase III tyrial of erlotinib versus docetaxel as second- or third-line therapy in patients with advanced non-small-cell lung cancer: docetaxel and erlotinib lung cancer rial (DELTA). J Clin Oncol. 2014;32:1902-8.

  Kawaguchi T, Ando M, Asami K, Okano Y, Fukuda M, Nakagawa H, Ibata H, Kozuki T, Endo T, Tamura A, Kamimura M, Sakamoto K, Yoshimi M, Soejima Y, Tomizawa Y, Isa S, Takada M, Saka H, Kubo A.

• 10. A multi-institutional phase II trial of consolidation S-1 after concurrent chemoradiotherapy with cisplatin and vinorelbine for locally advanced non-small cell lung cancer. Eur J Cancer. 2012;48:672-7.

  Kawaguchi T, Takada M, Ando M, Okishio K, Atagi S, Fujita Y, Tomizawa Y, Hayashihara K, Okano Y, Takahashi F, Saito R, Matsumura A, Tamura A.

• 11. Lung cancer in patients with chronic pyothorax. Respirology. 2008;13:585-9.

  Tamura A, Hebisawa A, Iuchi K, Maeda H, Fukai S, Komatsu H, Kawahara M.

• 12. Prognostic significance of thrombomodulin expression and vascular invasion in stage I squamous cell carcinoma of the lung. Lung Cancer 2001;34:375-82.

  Tamura A, Hebisawa A, Hayashi K, Sagara Y, Fukushima K, Kurashima A, Yotsumoto H, Mori M, Komatsu H.

• 13. Is thrombomodulin useful as a tumor marker of a lung cancer? Lung Cancer. 1996;15:189-95.

  Tamura A, Komatsu H, Hebisawa A, Kurashima A, Mori M, Katayama T.

• 14. Detection of thrombomodulin in human lung cancer cells. Am J Pathol. 1993;142:79-85.

  Tamura A, Matsubara O, Hirokawa K, Aoki N.

• 15. Cardiac metastasis of lung cancer. A study of metastatic pathways and clinical manifestations. Cancer. 1992;70:437-42.

  Tamura A, Matsubara O, Yoshimura N, Kasuga T, Akagawa S, Aoki N.